UM  > Faculty of Health Sciences
Residential Collegefalse
Status已發表Published
Identification of a novel coregulator, SH3YL1, that interacts with the androgen receptor n-terminus
Blessing A.M.2; Ganesan S.1,6; Rajapakshe K.4; Sung Y.Y.8; Bollu L.R.5; Shi Y.2; Cheung E.8,9; Coarfa C.4; Chang J.T.3; McDonnell D.P.6; Frigo D.E.2,7
2015-10-01
Source PublicationMolecular Endocrinology
ISSN0888-8809
Volume29Issue:10Pages:1426-1439
Abstract

Nuclear receptor (NR)-mediated transcriptional activity is a dynamic process that is regulated by the binding of ligands that induce distinct conformational changes in the NR. These structural alterations lead to the differential recruitment of coregulators (coactivators or corepressors) that control the expression of NR-regulated genes. Here, we show that a stretch of proline residues located within the N-terminus of androgen receptor (AR) is a bona fide coregulator binding surface, the disruption of which reduces the androgen-dependent proliferation and migration of prostate cancer (PCa) cells. Using T7 phage display, we identified a novel AR-interacting protein, Src homology 3 (SH3)-domain containing, Ysc84-like 1 (SH3YL1), whose interaction with the receptor is dependent upon this polyproline domain. As with mutations within the AR polyproline domain, knockdown of SH3YL1 attenuated androgen-mediated cell growth and migration. RNA expression analysis revealed that SH3YL1 was required for the induction of a subset of AR-modulated genes. Notable was the observation that ubinuclein 1 (UBN1), a key member of a histone H3.3 chaperone complex, was a transcriptional target of the AR/SH3YL1 complex, correlated with aggressive PCa in patients, and was necessary for the maximal androgen-mediated proliferation and migration of PCa cells. Collectively, these data highlight the importance of an amino-terminal activation domain, its associated coregulator, and downstream transcriptional targets in regulating cellular processes of pathological importance in PCa.

DOI10.1210/me.2015-1079
URLView the original
Indexed BySCIE
Language英語English
WOS Research AreaEndocrinology & Metabolism
WOS SubjectEndocrinology & Metabolism
WOS IDWOS:000366508500005
Scopus ID2-s2.0-84943226764
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionFaculty of Health Sciences
Corresponding AuthorFrigo D.E.
Affiliation1.Grifols Therapeutics Inc.
2.University of Houston
3.University of Texas Health Science Center at Houston
4.Baylor College of Medicine
5.University of Texas MD Anderson Cancer Center
6.Duke University School of Medicine
7.Methodist Hospital Houston
8.A-Star, Genome Institute of Singapore
9.Universidade de Macau
Recommended Citation
GB/T 7714
Blessing A.M.,Ganesan S.,Rajapakshe K.,et al. Identification of a novel coregulator, SH3YL1, that interacts with the androgen receptor n-terminus[J]. Molecular Endocrinology, 2015, 29(10), 1426-1439.
APA Blessing A.M.., Ganesan S.., Rajapakshe K.., Sung Y.Y.., Bollu L.R.., Shi Y.., Cheung E.., Coarfa C.., Chang J.T.., McDonnell D.P.., & Frigo D.E. (2015). Identification of a novel coregulator, SH3YL1, that interacts with the androgen receptor n-terminus. Molecular Endocrinology, 29(10), 1426-1439.
MLA Blessing A.M.,et al."Identification of a novel coregulator, SH3YL1, that interacts with the androgen receptor n-terminus".Molecular Endocrinology 29.10(2015):1426-1439.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Blessing A.M.]'s Articles
[Ganesan S.]'s Articles
[Rajapakshe K.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Blessing A.M.]'s Articles
[Ganesan S.]'s Articles
[Rajapakshe K.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Blessing A.M.]'s Articles
[Ganesan S.]'s Articles
[Rajapakshe K.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.